NCT05260554 is a clinical trial of Fosfomycin in Urinary Tract Disease, sponsored by Kırklareli University.

Who is sponsoring NCT05260554?

NCT05260554 is sponsored by Kırklareli University.

What drugs are being tested in NCT05260554?

Interventions in NCT05260554: Fosfomycin, Cranberry.

What condition does NCT05260554 study?

NCT05260554 studies Urinary Tract Disease, Cystitis, Antibiotic Reaction.

Is NCT05260554 still recruiting?

NCT05260554 is currently completed. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT05260554

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Cranberry Extract on the Urinary System

Completed Last updated 2 March 2022

What this trial tests

trial testing Fosfomycin in Urinary Tract Disease in 2 participants. Completed in 18 February 2022.

Timeline

26 January 2022

Primary endpoint
18 February 2022

18 February 2022

Quick facts

Lead sponsor	Kırklareli University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2
Start date	26 January 2022
Primary completion	18 February 2022
Estimated completion	18 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Fosfomycin (FOSFOMYCIN) — full drug profile →
Cranberry — full drug profile →

Conditions studied

Urinary Tract Disease — all drugs for Urinary Tract Disease →
Cystitis — all drugs for Cystitis →
Antibiotic Reaction — all drugs for Antibiotic Reaction →

Sponsor

Kırklareli University

Who can join

18 and older, any sex, with Urinary Tract Disease or Cystitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we will try to emphasize the effects of using cranberry tablets, which is an alternative to antibiotic therapy, during uncomplicated urinary tract infections (only urinary tract, bladder and kidney infections did not).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antibiotic versus cranberry in the treatment of uncomplicated urinary infection: a randomized controlled trial.
Güven O, Sayılan S, Tataroğlu Ö, Hökenek NM, et al · · 2023 · cited 2× · PMID 38126412 · DOI 10.1590/1806-9282.20230799

Verify or expand the search:

Other trials of Fosfomycin

Trials testing the same drug.

NCT05254808 — EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care · Phase 3 · terminated
NCT06814899 — Use of Fosfomycin in the Treatment of Bacterial Infections · recruiting
NCT03950544 — The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae · EARLY_PHASE1 · unknown
NCT03228108 — Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. · Phase 4 · completed
NCT05211011 — Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection · Phase 4 · unknown

Other recruiting trials for Urinary Tract Disease

Currently open trials in the same condition.

NCT05153694 — Infectious Complications After Cystectomy: A Prospective Observational Study · recruiting
NCT04288427 — 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy · NA · recruiting

Other Kırklareli University trials

Trials by the same sponsor.

NCT07074314 — The Effect of Laughter Yoga and Premenstrual Symptoms · NA · completed
NCT07064733 — Effect of Music and Warm Foot Bath Therapy on Pregnancy-Related Anxiety, Blood Pressure and Quality of Life · NA · recruiting
NCT06637891 — Mandala Coloring and Postpartum Blues · NA · completed
NCT06556927 — The Laughter, Pregnancy, Anxiety and Llife Quality · NA · recruiting
NCT06519513 — Laughter Yoga, Stress Level and Burnout Level · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05260554 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kırklareli University
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05260554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing